The neurovascular device market is projected to grow from USD 3.1 billion in 2025 to USD 4.0 billion by 2035, at a CAGR of 2.6%. Aneurysm Coiling And Embolization Devices will dominate with a 31.7% market share, while cerebral aneurysms will lead the disease pathology segment with a 26.9% share.